References
- Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–926.
- Yang S, Leong KF, Du Z, et al. The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. Tissue Eng. 2002;8:1–11.
- Stoop R. Smart biomaterials for tissue engineering of cartilage. Tissue Eng. 2001;7:679–689.
- Petite H, Viateau V, Bensaid W, et al. Tissue-engineered bone regeneration. Nat Biotechnol. 2000;18:959–963.
- Wang Q, Xu J, Jin H, et al. Artificial periosteum in bone defect repair – a review. Chin Chem Lett. 2017;28:1801–1807.
- Dimitriou R, Jones E, McGonagle D, et al. Bone regeneration: current concepts and future directions. BMC Med. 2011;9:66–76.
- Qazi TH, Mooney DJ, Pumberger M, et al. Biomaterials based strategies for skeletal muscle tissue engineering: existing technologies and future trends. Biomaterials. 2015;53:502–521.
- Stevens MM. Biomaterials for bone tissue engineering. Mater Today. 2008;11:18–25.
- Ajellal N, Thomas CM, Aubry T, et al. Encapsulation and controlled release of L-leuprolide from poly(β-hydroxyalkanoate)s: impact of microstructure and chemical functionalities. New J Chem. 2011;35:876–880.
- Wang D, Xuan L, Zhong H, et al. Incorporation of well-dispersed calcium phosphate nanoparticles into PLGA electrospunnano fibers to enhance the osteogenic induction potential. RSC Adv. 2017;7:23982–23993.
- Sun F, Shi T, Zhou T, et al. 3D poly(lactic-co-glycolic acid) scaffolds for treating spinal cord injury. J Biomed Nanotechnol. 2017;13:290–302.
- Fu S, Wang P, Chu B, et al. In vivo biocompatibility and osteogenesis of electrospun poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone)/nano-hydroxyapatite composite scaffold. Biomaterials. 2012;33:8363–8371.
- Ling Q, Wang T, Yu X, et al. UC-VEGF-SMC three dimensional (3D) nano scaffolds exhibits good repair function in bladder damage. J Biomed Nanotechnol. 2017;13:313–323.
- Shakir M, Jolly R, Khan MS, et al. Nano-hydroxyapatite/β-CD/chitosan nanocomposite for potential applications in bone tissue engineering. Int J Biol Macromol. 2016;93:276–289.
- Cunniffe GM, Curtin CM, Thompson EM, et al. Content-dependent osteogenic response of nanohydroxyapatite: an in vitro and in vivo assessment within collagen-based scaffolds. ACS Appl Mater Interfaces. 2016;8:23477–23488.
- Fujisaki K, Tadano S. Relationship between bone tissue strain and lattice strain of HAp crystals in bovine cortical bone under tensile loading. J Biomech. 2007;40:1832–1838.
- Amini AR, Laurencin CT, Nukavarapu SP. Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng. 2012;40:363–408.
- Place ES, George JH, Williams CK, et al. Synthetic polymer scaffolds for tissue engineering. Chem Soc Rev. 2009;38:1139–1151.
- Shearer MJ. Vitamin K. Lancet. 1995;345:229–234.
- Katti DS, Robinson KW, Ko FK, et al. Bioresorbablenano fiber-based systems for wound healing and drug delivery: optimization of fabrication parameters. J Biomed Mater Res. 2004;70:286–296.
- Das RK, Zouani OF, Labrugere C, et al. Influence of nanohelical shape and periodicity on stem cell fate. ACS Nano. 2013;7:3351–3361.
- Jeon O, Alsberg E. Regulation of stem cell fate in a three-dimensional micropatterned dual-crosslinked hydrogel system. Adv Funct Mater. 2013;23:4765–4775.
- Vilela C, Sousa AF, Fonseca AC, et al. The quest for sustainable polyesters – insights into the future. Polym Chem. 2014;5:3119–3141.
- Narendran K, Nanthini R. In vitro biocompatibility evaluation of biscoumarin based random copolyesters. New J Chem. 2015;39:4948–4956.
- Killi N, Paul VL, Gundloori RVN. Antibacterial non-woven nanofibers of curcumin acrylate oligomers. New J Chem. 2015;39:4464–4470.
- Heller J. Ocular delivery using poly(ortho esters). Adv Drug Deliv Rev. 2005;57:2053–2062.
- Migneco F, Huang Y-C, Birla RK, et al. Poly(glycerol-dodecanoate), a biodegradable polyester for medical devices and tissue engineering scaffolds. Biomaterials. 2009;30:6479–6484.
- Krishna L, Dhamodaran K, Jayadev C, et al. Nanostructured scaffold as a determinant of stem cell fate. Stem Cell Res Ther. 2016;7:188.
- Galli C, Piemontese M, Lumetti S, et al. Actin cytoskeleton controls activation of Wnt/β-catenin signaling in mesenchymal cells on implant surfaces with different topographies. Acta Biomater. 2012;8:2963–2968.
- Ozdemir T, Xu LC, Siedlecki C, et al. Substrate curvature sensing through Myosin IIaupregulates early osteogenesis. Integr Biol. 2013;5:1407–1416.
- Shi M, Chen Z, Farnaghi S, et al. Copper-doped mesoporous silica nanospheres, a promising immunomodulatory agent for inducing osteogenesis. Acta Biomaterial. 2016;30:334–344.
- Cai X, Xie J, Yao Y, et al. Angiogenesis in a 3D model containing adipose tissue stem cells and endothelial cells is mediated by canonical Wnt signaling. Bone Res. 2017;5:17048.
- Ohji T, Fukushima M. Macro-porous ceramics: processing and properties. Int Mater Rev. 2012;57:115–131.
- Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin. J Biol Chem. 1974;249:6347–6350.
- Shimizu T, Takahata M, Kameda Y, et al. Vitamin K-dependent carboxylation of osteocalcin affects the efficacy of teriparatide (PTH(1-34)) for skeletal repair. Bone. 2014;64:95–101.
- Price PA, Williamson MK, Lothringer JW. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem. 1981;256:12760–12766.
- Hoang QQ, Sicheri F, Howard AJ, et al. Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature. 2003;425:977–980.
- Stenflo J, Fernlund P, Egan W, et al. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA. 1974;71:2730–2733.
- Hauschka PV, Lian JB, Gallop PM. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA. 1975;72:3925–3939.
- Abrahams MJ, Price J, Whitlock FA, et al. The Brisbane floods, January 1974: their impact on health. Med J Aust. 1976;2:936–939.